Table 2 Univariable analysis of perioperative morbidity in Non-IBD and IBD patients (n = 233)
n (%) | Major morbidity (Clavien Dindo ≥ IIIb) | Morbidity (Clavien Dindo ≥ I) | |||||
|---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Harzard ratio | 95% CI | P value | ||
Gender | .283 | .506 | |||||
Male | 156 (67.0) | ||||||
Female | 77 (33.0) | ||||||
Age | .611 | .372 | |||||
≤ 60 | 116 (49.8) | ||||||
> 60 | 117 (50.2) | ||||||
BMI | .626 | .061 | |||||
≤ 30 | 154 (66.1) | ||||||
> 30 | 61 (38.6) | ||||||
ASA | .632 | .813 | |||||
≤ II | 143 (61.4) | ||||||
> II | 90 (38.6) | ||||||
CVD | .458 | .217 | |||||
Present | 41 (17.6) | ||||||
Absent | 192 (82.4) | ||||||
CKD | .816 | .591 | |||||
Present | 30 (12.9) | ||||||
Absent | 203 (87.1) | ||||||
DM | .998 | .994 | |||||
Present | 42 (18.0) | ||||||
Absent | 191 (82.0) | ||||||
CRD | .322 | .371 | |||||
Present | 23 (9.9) | ||||||
Absent | 210 (90.1) | ||||||
History of malignancy | .474 | .098 | |||||
Present | 55 (23.6) | ||||||
Absent | 178 (76.4) | ||||||
IBD | .005 | .164 | |||||
Present | 34 (14.6) | 4.43 | 1.58–12.41 | ||||
Absent | 199 (85.4) | 1 | |||||
Intraoperative blood transfusion | .012 | .999 | |||||
Yes | 4 (1.7) | 13.31 | 1.76–100.83 | ||||
No | 229 (98.3) | 1 | |||||
Intensive care | .283 | .001 | |||||
Yes | 32 (13.7) | 3.50 | 1.63–7.52 | ||||
No | 201 (86.3) | ||||||